Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Screening for liver metastases in women with mammary carcinoma: comparison of contrast-enhanced ultrasound and magnetic resonance imaging.

Hänle MM, Thiel R, Saur G, Mason RA, Pauls S, Kratzer W.

Clin Imaging. 2011 Sep-Oct;35(5):366-70. doi: 10.1016/j.clinimag.2010.09.004.

PMID:
21872126
2.

Detection of hepatic metastases with low MI real time contrast enhanced sonography and SonoVue.

Oldenburg A, Hohmann J, Foert E, Skrok J, Hoffmann CW, Frericks B, Wolf KJ, Albrecht T.

Ultraschall Med. 2005 Aug;26(4):277-84.

PMID:
16123921
3.

New real-time image fusion technique for characterization of tumor vascularisation and tumor perfusion of liver tumors with contrast-enhanced ultrasound, spiral CT or MRI: first results.

Jung EM, Schreyer AG, Schacherer D, Menzel C, Farkas S, Loss M, Feuerbach S, Zorger N, Fellner C.

Clin Hemorheol Microcirc. 2009;43(1-2):57-69. doi: 10.3233/CH-2009-1221.

PMID:
19713601
4.

[Baseline and contrast-enhanced ultrasound of the liver in tumor patients].

Oldenburg A, Albrecht T.

Ultraschall Med. 2008 Oct;29(5):488-98. doi: 10.1055/s-2008-1027195. German.

PMID:
19241505
5.

Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.

Seitz K, Strobel D, Bernatik T, Blank W, Friedrich-Rust M, Herbay Av, Dietrich CF, Strunk H, Kratzer W, Schuler A.

Ultraschall Med. 2009 Aug;30(4):383-9. doi: 10.1055/s-0028-1109673. Epub 2009 Aug 17.

PMID:
19688670
6.

Contrast-enhanced ultrasonography (CEUS) vs. MRI of the small bowel in the evaluation of Crohn's disease activity.

Malagò R, D'Onofrio M, Mantovani W, D'Alpaos G, Foti G, Pezzato A, Caliari G, Cusumano D, Benini L, Pozzi Mucelli R.

Radiol Med. 2012 Mar;117(2):268-81. doi: 10.1007/s11547-011-0783-5. Epub 2012 Jan 21.

PMID:
22271005
7.

Three-dimensional contrast enhanced ultrasound score and dynamic contrast-enhanced magnetic resonance imaging score in evaluating breast tumor angiogenesis: correlation with biological factors.

Jia WR, Chai WM, Tang L, Wang Y, Fei XC, Han BS, Chen M.

Eur J Radiol. 2014 Jul;83(7):1098-105. doi: 10.1016/j.ejrad.2014.03.027. Epub 2014 Apr 12.

PMID:
24794865
8.

Contrast enhanced ultrasound in the detection of liver metastases: a prospective multi-centre dose testing study using a perfluorobutane microbubble contrast agent (NC100100).

Correas JM, Low G, Needleman L, Robbin ML, Cosgrove D, Sidhu PS, Harvey CJ, Albrecht T, Jakobsen JA, Brabrand K, Jenett M, Bates J, Claudon M, Leen E.

Eur Radiol. 2011 Aug;21(8):1739-46. doi: 10.1007/s00330-011-2114-6. Epub 2011 Apr 10.

PMID:
21479856
9.

Contrast-enhanced sonography in the characterization of small hepatocellular carcinomas in cirrhotic patients: comparison with contrast-enhanced ultrafast magnetic resonance imaging.

Giorgio A, De Stefano G, Coppola C, Ferraioli G, Esposito V, Di Sarno A, Giorgio V, De Stefano M, Sangiovanni V, Liorre G, Del Viscovo L.

Anticancer Res. 2007 Nov-Dec;27(6C):4263-9.

10.

[Application of contrast-enhanced ultrasound to increase the diagnostic rate of liver tumor by biopsy].

Wu W, Chen MH, Yan K, Yin SS, Dai Y, Fan ZH, Yang W, Li JY.

Zhonghua Yi Xue Za Zhi. 2006 Jan 10;86(2):116-20. Chinese.

PMID:
16620718
11.

Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).

Strobel D, Seitz K, Blank W, Schuler A, Dietrich CF, von Herbay A, Friedrich-Rust M, Bernatik T.

Ultraschall Med. 2009 Aug;30(4):376-82. doi: 10.1055/s-0028-1109672. Epub 2009 Aug 17.

PMID:
19688669
12.
13.

Characterisation of focal liver lesions undetermined at grey-scale US: contrast-enhanced US versus 64-row MDCT and MRI with liver-specific contrast agent.

Bartolotta TV, Taibbi A, Midiri M, La Grutta L, De Maria M, Lagalla R.

Radiol Med. 2010 Aug;115(5):714-31. doi: 10.1007/s11547-010-0506-3. Epub 2010 Jan 15. English, Italian.

PMID:
20082225
14.

The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer.

Fischer U, Zachariae O, Baum F, von Heyden D, Funke M, Liersch T.

Eur Radiol. 2004 Oct;14(10):1725-31. Epub 2004 Jul 10.

PMID:
15248080
15.
16.

Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

Forner A, Vilana R, Ayuso C, Bianchi L, Solé M, Ayuso JR, Boix L, Sala M, Varela M, Llovet JM, Brú C, Bruix J.

Hepatology. 2008 Jan;47(1):97-104. Erratum in: Hepatology. 2008 Feb;47(2):769.

PMID:
18069697
17.

Contrast enhanced ultrasound for the diagnosis of liver hemangiomas in clinical practice.

Sirli R, Sporea I, Popescu A, Dănilă M, Martie A, Bota S, Jurchis A, Sendroiu M.

Med Ultrason. 2011 Jun;13(2):95-101.

18.

Improved detection of hepatic metastases of adrenocortical cancer by contrast-enhanced ultrasound.

Bauditz J, Quinkler M, Beyersdorff D, Wermke W.

Oncol Rep. 2008 May;19(5):1135-9.

PMID:
18425368
19.

Differentiation between benign and malignant adrenal mass using contrast-enhanced ultrasound.

Friedrich-Rust M, Glasemann T, Polta A, Eichler K, Holzer K, Kriener S, Herrmann E, Nierhoff J, Bon D, Bechstein WO, Vogl T, Zeuzem S, Bojunga J.

Ultraschall Med. 2011 Oct;32(5):460-71. doi: 10.1055/s-0031-1273408. Epub 2011 Jun 10.

PMID:
21667434
20.

Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging.

Ricci P, Cantisani V, Ballesio L, Pagliara E, Sallusti E, Drudi FM, Trippa F, Calascibetta F, Erturk SM, Modesti M, Passariello R.

Ultraschall Med. 2007 Feb;28(1):57-62.

PMID:
17304413
Items per page

Supplemental Content

Write to the Help Desk